A new analysis of the Women’s Health Initiative trials found that menopausal hormone therapy effectively reduces vasomotor symptoms without increasing cardiovascular risk in women aged 50 to 59 years....
The phase 3 SERENA-6 trial evaluated whether replacing an aromatase inhibitor with camizestrant while continuing a CDK4/6 inhibitor in patients with ER-positive, HER2-negative advanced breast cancer and...
A recent study found that daily supplementation with myo-inositol during pregnancy did not reduce the risk of gestational diabetes, preeclampsia, or preterm birth in individuals with polycystic ovary...
In a multicenter trial of women with low-prognosis in vitro fertilization, investigators compared the effectiveness and safety of elective freeze-all versus fresh embryo transfer.
Recent findings presented at the American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting 2025 support several effective pain-reducing methods for outpatient...
The results from a randomized, placebo-controlled trial showed that oral probiotic supplementation did not reduce the recurrence of vulvovaginal infections in pregnant women following successful treatment....
In an analysis of six randomized trials, ciprofol significantly lowered the incidence of injection site pain without compromising anesthetic efficacy, suggesting a potential alternative to propofol for...
In an FDA panel held on July 21, 2025, experts discussed the nuances of risk-benefit counseling and stronger warnings for selective serotonin reuptake inhibitors (SSRIs) to ensure informed consent among...
A new analysis of national inpatient data reveals that women with both diabetes and polycystic ovary syndrome (PCOS) experience similar hospital outcomes to those without PCOS but face a significantly lower...
A randomized, double-blind, placebo-controlled crossover study found that a single 300 mg dose of palmitoylethanolamide significantly reduced acute menstrual pain compared with placebo at multiple early...
